UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat

Läkartidningen, 2000-11, Vol.97 (48), p.5590

Tärnvik, A

2000

Link zum Volltext

Verfügbarkeit prüfen

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis

Bulletin of the World Health Organization, 2001, Vol.79 (1), p.61-68

2001

Link zum Volltext

Verfügbarkeit prüfen

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

The New England journal of medicine, 2022-12, Vol.387 (25), p.2331-2343

2022

Link zum Volltext

Verfügbarkeit prüfen

Quinoline: A promising antitubercular target

Biomedicine & pharmacotherapy, 2014-10, Vol.68 (8), p.1161-1175

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

The New England journal of medicine, 2020-03, Vol.382 (10), p.893-902

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing

Journal of controlled release, 2017-12, Vol.268, p.40-48

2017

Link zum Volltext

Verfügbarkeit prüfen

Telacebec (Q203), a New Antituberculosis Agent

The New England journal of medicine, 2020-03, Vol.382 (13), p.1280-1281

2020

Link zum Volltext

Verfügbarkeit prüfen

Latent Mycobacterium tuberculosis Infection

The New England journal of medicine, 2015-05, Vol.372 (22), p.2127-2135

2015

Link zum Volltext

Verfügbarkeit prüfen

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

The Lancet infectious diseases, 2013, Vol.13 (1), p.27-35

2013

Link zum Volltext

Verfügbarkeit prüfen

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children

The New England journal of medicine, 2022-03, Vol.386 (10), p.911-922

2022

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization

PLoS medicine, 2019-04, Vol.16 (4), p.e1002773

2019

Link zum Volltext

Verfügbarkeit prüfen

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

The New England journal of medicine, 2019-03, Vol.380 (13), p.1201-1213

2019

Link zum Volltext

Verfügbarkeit prüfen

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Nature medicine, 2018-11, Vol.24 (11), p.1708-1715

2018

Link zum Volltext

Verfügbarkeit prüfen

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

The New England journal of medicine, 2019-03, Vol.380 (11), p.1001-1011

2019

Link zum Volltext

Verfügbarkeit prüfen

Antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of Psidium guineense Sw. and spathulenol

Journal of ethnopharmacology, 2018-01, Vol.210, p.351-358

2018

Link zum Volltext

Verfügbarkeit prüfen

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial

Annals of internal medicine, 2017-11, Vol.167 (10), p.689

2017

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic resistance mechanisms in M. tuberculosis: an update

Archives of Toxicology. Archiv für Toxikologie, 2016-07, Vol.90 (7), p.1585-1604

Nguyen, Liem

2016

Link zum Volltext

Verfügbarkeit prüfen

Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies

International journal of pharmaceutics, 2016-01, Vol.497 (1-2), p.199-209

2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

The Lancet (British edition), 2018-09, Vol.392 (10150), p.821-834

2018

Link zum Volltext

Verfügbarkeit prüfen

Towards tuberculosis elimination: an action framework for low-incidence countries

The European respiratory journal, 2015-04, Vol.45 (4), p.928-952

2015

Link zum Volltext

Verfügbarkeit prüfen

Management of drug-resistant tuberculosis

The Lancet (British edition), 2019-09, Vol.394 (10202), p.953-966

2019

Link zum Volltext

Verfügbarkeit prüfen

Respirable nanocarriers as a promising strategy for antitubercular drug delivery

Journal of controlled release, 2014-08, Vol.187, p.183-197

2014

Link zum Volltext

Verfügbarkeit prüfen

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

The New England journal of medicine, 2011-12, Vol.365 (23), p.2155-2166

2011

Link zum Volltext

Verfügbarkeit prüfen

Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis

Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5485-5492

2011

Link zum Volltext

Verfügbarkeit prüfen

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

The New England journal of medicine, 2016-01, Vol.374 (2), p.124-134

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 12.339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(9.694)
Mit Volltextzugriff
(8.974)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(8.937)
Science & Technology
(8.269)
Life Sciences & Biomedicine
(7.634)
Antitubercular Agents - Administration & Dosage
(5.431)
Male
(4.532)
Tuberculosis
(4.398)
Female
(4.272)
Adult
(3.610)
Antitubercular Agents - Therapeutic Use
(3.604)
Infectious Diseases
(2.759)
Tuberculosis, Pulmonary - Drug Therapy
(2.655)
Middle Aged
(2.651)
Tuberculosis - Drug Therapy
(2.312)
Pharmacology & Pharmacy
(2.077)
Biological And Medical Sciences
(2.061)
Medical Sciences
(2.037)
Drug Therapy, Combination
(1.875)
Treatment Outcome
(1.684)
Animals
(1.622)
Adolescent
(1.532)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(6.367)
Ingenta E-Journals
(4.960)
IngentaConnect Journals
(3.575)
RCN full-text journals@Ovid
(3.327)
Single Journals
(1.628)
Springer journals
(1.228)
Elsevier ScienceDirect Journals Complete
(1.096)
Wiley Online Library Journals
(1.068)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(718)
Wiley Online Library
(717)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(544)
Taylor & Francis
(480)
Taylor & Francis Journals Complete
(413)
Oxford Journals Online Current
(399)
Oxford Journals 2020 Medicine
(350)
Ebook Central Perpetual and DDA
(345)
eBooks on EBSCOhost
(339)
Nexis
(317)
JSTOR
(289)
Nature Journals
(198)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(18)
... seit 90 Tagen
(71)

Menü

Weitere Dienste

Einstellungen

Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Quinoline: A promising antitubercular target

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing

Telacebec (Q203), a New Antituberculosis Agent

Latent Mycobacterium tuberculosis Infection

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children

Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of Psidium guineense Sw. and spathulenol

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial

Antibiotic resistance mechanisms in M. tuberculosis: an update

Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Towards tuberculosis elimination: an action framework for low-incidence countries

Management of drug-resistant tuberculosis

Respirable nanocarriers as a promising strategy for antitubercular drug delivery

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

Suchergebnisse filtern